Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Here are the three most used drugs on the Medicare price negotiation list
01:52pm, Tuesday, 29'th Aug 2023
The Biden administration unveiled the much-awaited list officially kicking off a process that aims to control rising drug costs in the U.S.
Biden Targets J&J, Bristol Drugs for Medicare Price Cuts
12:50pm, Tuesday, 29'th Aug 2023
The Biden administration says 10 prescription drugs will be subject to price negotiations with Medicare. The White House says some prices could be cut in half.
10 Drugs Selected for Medicare Price Reduction
12:01pm, Tuesday, 29'th Aug 2023
We're getting Case-Shiller home price numbers ahead of the opening bell this morning, but there's not enough time to dig into it. Give us till this afternoon to speak about these.
Bristol Myers (BMY) Gets FDA Nod for Reblozyl Label Expansion
10:31am, Tuesday, 29'th Aug 2023
Bristol Myers' (BMY) Reblozyl is now indicated in the United States as the first-line treatment of anemia in adults with lower-risk MDS who may require transfusions.
Bristol-Myers Squibb: Top Defensive Pick During Recessions With A Value Proposition
02:20am, Thursday, 24'th Aug 2023
Bristol-Myers has a strong history of investment outperformance during equity bear markets and recessions. The company is uniquely undervalued, with a low 8x P/E and nearly 4% cash dividend yield. Aft
Biotech Breakthroughs: 3 Companies on the Cusp of Major Discoveries
07:42pm, Wednesday, 23'rd Aug 2023
Artificial intelligence is changing the drug-discovery process by making it much faster and cheaper. Traditionally, most biotech stock drug candidates fail.
Bristol Myers' (BMY) Opdivo Gets EC Nod for Label Expansion
12:47pm, Wednesday, 23'rd Aug 2023
Bristol Myers (BMY) obtains approval in the EU for Opdivo for the adjuvant treatment of adults and adolescents with stage IIB or IIC melanoma who have undergone complete resection.
3 Sorry Pharma Stocks to Sell in August Before It's Too Late
04:38pm, Tuesday, 22'nd Aug 2023
Pharmaceutical stocks can bring you from rags to riches — and back to rags again. The truth is the innovative sector can function similarly to a lottery.
Bristol Myers (BMY) Announces Positive Updated NSCLC Data
01:17pm, Thursday, 17'th Aug 2023
Bristol Myers' (BMY) repotrectinib shows durable efficacy benefits in patients with locally advanced or metastatic ROS1-Positive non-small cell lung cancer.
Pharma stocks are typically shunned by Wall St. when people feel confident about economy: Jim Cramer
07:32pm, Wednesday, 16'th Aug 2023
'Mad Money' host Jim Cramer talks the Pharma industry facing off against the federal government over IRA provisions.
2 Dividend Stocks to Buy Hand Over Fist
09:53am, Wednesday, 16'th Aug 2023
Bristol Myers Squibb's declining revenue growth won't last forever. Microsoft has a strong moat and plenty of avenues for expansion.
What pharma brands will be impacted by Medicare price negotiations
02:59pm, Monday, 14'th Aug 2023
Jared Holz, Mizuho healthcare strategist, joins 'The Exchange' to discuss Medicare drug price negotiations, the M&A impact of government intervention into drug pricing, and more.
2 Blue Chip Dividend Stocks That Are Top Buys in August
02:36pm, Monday, 14'th Aug 2023
Blue chip dividend stocks can be outstanding picks for investors with a long-term outlook. Abbott Laboratories and Bristol Myers Squibb are two top-shelf pharma stocks that stand out from the crowd.
Pharma ETFs in Focus Post Q2 Earnings
01:47pm, Friday, 11'th Aug 2023
Second-quarter earnings beat ratio of 86.6% and revenue beat ratio of 84.9% for the healthcare sector are impressive.
Final Trades: Bristol Myers, Toast & more
02:11pm, Thursday, 10'th Aug 2023
The "Halftime Report" traders give their top picks to watch for the second half.
